Skip to content

Study on Effectivenesss of Jatamansi Arka in managing ADHD in children

Efficacy of jatamansi arka in Attention-Deficit/ Hyperactive Disorder in children - Single Arm Interventional Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085820
Enrollment
30
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of either sex in between age group of 5 to 10 years. 2.Known case of ADHD. 3.Children with average/normal IQ 4.Subjects satisfying DSM-5 criteria of diagnosis

Exclusion criteria

Exclusion criteria: 1.Children with any critical mental disease. 2.Children with known gross physical disability. 3.Children with any known genetic disorder and congenital disorder. 4.Children with any associated long term or fatal disease. Children with known systemic disorder like Diabetes Mellitus, Nephrotic syndrome etc.

Design outcomes

Primary

MeasureTime frame
To assess the change in grading of NICHQ Vanderbilt Assessment scale.Timepoint: At baseline, 15th, 30th, 45th, 60th, 75th ,90th, 120th day

Secondary

MeasureTime frame
Improve in the quality of life by improvement in cognition (Montreal Cognitive Assessment Scale-MoCA) & concentration with safe & effective treatment.Timepoint: At baseline & 120th day

Countries

India

Contacts

Public ContactDr Rakesh Kumar Nagar

National Institute of Ayurveda Jaipur

drrknagar@gmail.com09414062099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026